BMO Capital Markets Reiterates Hold Rating for National Health Investors, Inc. (NHI)

National Health Investors, Inc. (NYSE:NHI)‘s stock had its “hold” rating reiterated by equities research analysts at BMO Capital Markets in a research report issued on Wednesday. They currently have a $80.00 price objective on the real estate investment trust’s stock. BMO Capital Markets’ price target suggests a potential upside of 3.32% from the company’s current price.

NHI has been the subject of a number of other research reports. BidaskClub cut shares of National Health Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, September 6th. Mizuho reaffirmed a “hold” rating and issued a $82.00 price objective on shares of National Health Investors in a research note on Wednesday, October 4th. Stifel Nicolaus upped their price objective on shares of National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Wednesday, June 21st. Finally, KeyCorp reaffirmed a “hold” rating on shares of National Health Investors in a research note on Sunday, September 17th. One analyst has rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. National Health Investors currently has a consensus rating of “Hold” and a consensus target price of $80.14.

National Health Investors (NYSE:NHI) opened at 77.43 on Wednesday. The stock’s 50 day moving average is $78.75 and its 200 day moving average is $76.90. The company has a market cap of $3.17 billion, a P/E ratio of 19.88 and a beta of 0.56. National Health Investors has a 1-year low of $66.31 and a 1-year high of $81.21.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The business had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. During the same period last year, the company posted $1.22 EPS. National Health Investors’s revenue for the quarter was up 14.1% on a year-over-year basis. Equities analysts anticipate that National Health Investors will post $3.86 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://ledgergazette.com/2017/10/18/bmo-capital-markets-reiterates-hold-rating-for-national-health-investors-inc-nhi.html.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the sale, the insider now directly owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 5.19% of the company’s stock.

Large investors have recently bought and sold shares of the stock. Schwab Charles Investment Management Inc. raised its holdings in National Health Investors by 9.7% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 161,309 shares of the real estate investment trust’s stock valued at $11,716,000 after buying an additional 14,297 shares during the last quarter. BlackRock Inc. raised its holdings in National Health Investors by 6,473.4% during the 1st quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock valued at $241,753,000 after buying an additional 3,277,930 shares during the last quarter. Bank of America Corp DE raised its holdings in National Health Investors by 2.5% during the 1st quarter. Bank of America Corp DE now owns 388,780 shares of the real estate investment trust’s stock valued at $28,238,000 after buying an additional 9,538 shares during the last quarter. Tocqueville Asset Management L.P. raised its holdings in National Health Investors by 2.3% during the 2nd quarter. Tocqueville Asset Management L.P. now owns 4,400 shares of the real estate investment trust’s stock valued at $348,000 after buying an additional 100 shares during the last qua

NHI has been the subject of a number of other research reports. BidaskClub cut shares of National Health Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, September 6th. Mizuho reaffirmed a “hold” rating and issued a $82.00 price objective on shares of National Health Investors in a research note on Wednesday, October 4th. Stifel Nicolaus upped their price objective on shares of National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Wednesday, June 21st. Finally, KeyCorp reaffirmed a “hold” rating on shares of National Health Investors in a research note on Sunday, September 17th. One analyst has rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. National Health Investors currently has a consensus rating of “Hold” and a consensus target price of $80.14.

National Health Investors (NYSE:NHI) opened at 77.43 on Wednesday. The stock’s 50 day moving average is $78.75 and its 200 day moving average is $76.90. The company has a market cap of $3.17 billion, a P/E ratio of 19.88 and a beta of 0.56. National Health Investors has a 1-year low of $66.31 and a 1-year high of $81.21.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The business had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. During the same period last year, the company posted $1.22 EPS. National Health Investors’s revenue for the quarter was up 14.1% on a year-over-year basis. Equities analysts anticipate that National Health Investors will post $3.86 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another website, it was stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this piece can be accessed at https://ledgergazette.com/2017/10/18/bmo-capital-markets-reiterates-hold-rating-for-national-health-investors-inc-nhi.html.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the sale, the insider now directly owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 5.19% of the company’s stock.

Large investors have recently bought and sold shares of the stock. Schwab Charles Investment Management Inc. raised its holdings in National Health Investors by 9.7% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 161,309 shares of the real estate investment trust’s stock valued at $11,716,000 after buying an additional 14,297 shares during the last quarter. BlackRock Inc. raised its holdings in National Health Investors by 6,473.4% during the 1st quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock valued at $241,753,000 after buying an additional 3,277,930 shares during the last quarter. Bank of America Corp DE raised its holdings in National Health Investors by 2.5% during the 1st quarter. Bank of America Corp DE now owns 388,780 shares of the real estate investment trust’s stock valued at $28,238,000 after buying an additional 9,538 shares during the last quarter. Tocqueville Asset Management L.P. raised its holdings in National Health Investors by 2.3% during the 2nd quarter. Tocqueville Asset Management L.P. now owns 4,400 shares of the real estate investment trust’s stock valued at $348,000 after buying an additional 100 shares during the last quarter. Finally, Prudential Financial Inc. raised its holdings in National Health Investors by 137.4% during the 2nd quarter. Prudential Financial Inc. now owns 13,683 shares of the real estate investment trust’s stock valued at $1,084,000 after buying an additional 7,920 shares during the last quarter. Institutional investors own 70.11% of the company’s stock.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply